Package Insert: Information for the User
Ixia Plus 20 mg/25 mg Film-Coated Tablets
Read this package insert carefully before starting to take this medication, because it contains important information for you.
-Keep this package insert, as you may need to read it again.
-If you have any questions, consult your doctor or pharmacist.
-This medication has been prescribed only for you, and you should not give it to others even if they have the same symptoms as you, as it may harm them.
-If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this package insert. See section 4.
Ixia Plus contains two active ingredients, olmesartan medoxomil and hydrochlorothiazide, which are used in the treatment of high blood pressure (hypertension):
Ixia Plus will only be given if treatment with Ixia (olmesartan medoxomil) alone has not adequately controlled your blood pressure. The concurrent administration of both active ingredients in Ixia Plus contributes to reducing blood pressure more than if each active ingredient were administered alone.
You may already be taking medications to treat high blood pressure, but your doctor may believe it necessary for you to take Ixia Plus to lower it further.
High blood pressure can be controlled with medications like Ixia Plus tablets. Your doctor has probably also recommended that you make some lifestyle changes to help lower your blood pressure (for example, losing weight, quitting smoking, reducing alcohol consumption, and reducing the amount of salt in your diet). Your doctor may also have recommended that you engage in regular exercise, such as walking or swimming. It is essential to follow your doctor's advice.
Do not take Ixia Plus
If you think you fall into any of these cases, or are unsure, do not take the tablets. Talk to your doctor and follow their advice.
Warnings and precautions
Consult your doctor before starting to use Ixia Plus.
Before taking the tablets,tell your doctorif you are taking any of the following medicines used to treat high blood pressure (hypertension):
Your doctor may check your kidney function, blood pressure and electrolyte levels in your blood (for example, potassium) at regular intervals.
See also the information under the heading “Do not take Ixia Plus”.
Before taking the tablets,tell your doctorif you have any of the following health problems:
Contact your doctor if you experience any of the following symptoms:
Your doctor may want to see you more often and do some tests if you have any of these problems.
Consult your doctor if you experience abdominal pain, nausea, vomiting or diarrhoea after taking Ixia Plus. Your doctor will decide whether to continue treatment. Do not stop taking Ixia Plus on your own.
Ixia Plus may cause an increase in levels of fats and uric acid in your blood. Your doctor will probably want to do blood tests from time to time to check for these possible changes.
You may experience changes in the levels of certain chemicals in your blood called electrolytes. Your doctor will probably want to do blood tests from time to time to check for this possible change. Some signs of electrolyte changes are: thirst, dry mouth, muscle pain or cramps, tired muscles, low blood pressure (hypotension), feeling weak, slow, tired, drowsy or restless, nausea, vomiting, decreased need to urinate, rapid heart rate.Tell your doctor if you notice any of these symptoms.
Like any other medicine that lowers blood pressure, an excessive decrease in blood pressure in patients with heart or brain blood flow problems may cause a heart attack or stroke. Your doctor will carefully monitor your blood pressure.
If you are to have tests of parathyroid function, stop taking Ixia Plus before the tests are done.
It is reported to athletes that this medicine contains a component that may establish a positive analytical result for doping control.
Inform your doctor if you are pregnant or think you may be pregnant. Ixia Plus is not recommended for use at the start of pregnancy, and should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken at this stage (see Pregnancy section).
Children and adolescents
Ixia Plus is not recommended for children and adolescents under 18 years.
Use of Ixia Plus with other medicines
Inform your doctor or pharmacist if you are taking, have recently taken or may need to take any other medicine.
Particularly, inform your doctor or pharmacist about any of the following medicines:
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Ixia Plus” and “Warnings and precautions”).
-Potassium supplements (as well as salt substitutes that contain potassium).
-Medicines that increase urine production (diuretics).
-Heparin (to thin the blood).
-Laxatives.
-Glucocorticoids.
-Adrenocorticotropic hormone (ACTH).
-Carbenoxolone (medicine for the treatment of mouth and stomach ulcers).
-Penicillin G sodium (antibiotic also called benzylpenicillin sodium).
-Some analgesics such as aspirin or salicylates.
Ixia Plus can be taken with or without food.
Be careful when drinking alcohol while taking Ixia Plus, as some people may feel weak or dizzy. If this happens, do not drink any alcohol, including wine, beer or alcoholic drinks.
Black patients
Like other similar medicines, the blood pressure-lowering effect of Ixia Plus is somewhat less in black patients.
Pregnancy
Inform your doctor if you are pregnant, (or if you suspect you may be). Your doctor will usually advise you to stop taking Ixia Plus before becoming pregnant or as soon as you know you are pregnant, and will recommend that you take another medicine instead of Ixia Plus. Ixia Plus is not recommended for use during pregnancy, and should not be taken after the third month of pregnancy, as it may cause serious harm to your baby if taken at this stage.
Breastfeeding
Inform your doctor if you are breastfeeding or are about to start. Ixia Plus is not recommended for use during breastfeeding, and your doctor will choose another treatment for you if you wish to breastfeed.
If you are pregnant or breastfeeding, think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medicine.
Use in athletes
It is reported to athletes that this medicine contains a component (hydrochlorothiazide) that may establish a positive analytical result for doping control.
You may feel drowsy or dizzy while taking Ixia Plus for high blood pressure. If this happens, do not drive or operate machines until the symptoms have disappeared. Consult your doctor.
Ixia Plus contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine..
Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
The recommended doseis 1 Ixia Plus 20 mg/12.5 mg tablet per day. If blood pressure is not adequately controlled, your doctor may change the dose to 1 Ixia Plus 20 mg/25 mg tablet per day.
Take the tablets with water. If possible, take your doseat the same time every day, for example, with breakfast. It is essential to continue taking Ixia Plus until your doctor tells you to stop.
If you take more Ixia Plus than you should
If you take more tablets than you should or if a child accidentally ingests one or more tablets, contact your doctor immediately or go to the nearest hospital emergency center and bring the medication packaging with you.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Ixia Plus
If you forget to take a daily dose, take the usual dose the next day.Do nottake a double dose to compensate for the missed doses.
If you interrupt treatment with Ixia Plus
It is essential to continue taking Ixia Plus, unless your doctor tells you to stop.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
However, the following side effects can be serious:
Ixia Plus is a combination of two active principles. The following information, first, describes the side effects reported so far with the Ixia Plus combination (in addition to those already mentioned) and, second, the known side effects of the two active principles separately.
These are other side effects known so far with Ixia Plus:
If these effects occur, they are often mild anddo not need to interrupt treatment.
Frequent side effects (can affect up to 1 in 10 people):
Dizziness, weakness, headache, fatigue, chest pain, swelling of ankles, feet, legs, hands, or arms.
Rare side effects (can affect up to 1 in 100 people):
Fast and intense heart palpitations, hives, eczema, dizziness, cough, indigestion, abdominal pain, nausea, vomiting, diarrhea, muscle cramps, and muscle pain, joint pain, arm and leg pain, back pain, erectile dysfunction in men, blood in urine.
Also, some changes in blood tests have been observed, including:
Increased levels of blood fat, increased urea or uric acid in blood, increased creatinine, increased or decreased levels of potassium in blood, increased levels of calcium in blood, increased blood sugar, increased values of liver function tests. Your doctor will monitor you through a blood test and tell you if you need to take any measures.
Rare side effects (can affect up to 1 in 1,000 people):
Unpleasant sensation,altered consciousness, skin swelling (hives), acute renal insufficiency.
Also, some changes in blood test results have been observed, including:
Increased urea in blood, decreased values of hemoglobin and hematocrit. Your doctor will monitor you through a blood test and tell you if you need to take any measures.
Additional side effects reported with the use of olmesartan medoxomil or hydrochlorothiazide alone, but not with Ixia Plus or in a higher frequency:
Olmesartan medoxomil:
Frequent side effects (can affect up to 1 in 10 people):
Bronchitis, cough, congestion and nasal secretion, sore throat, abdominal pain, indigestion, diarrhea, nausea, gastroenteritis, joint or bone pain, back pain, blood in urine, urinary tract infection, flu-like symptoms, pain.
Also, some changes in blood test results have been observed, including:
Increased levels of blood fat, increased urea or uric acid in blood, increased levels of liver or muscle function.
Rare side effects (can affect up to 1 in 100 people):
Fast and intense allergic reactions that can affect the entire body and can cause breathing problems, as well as a rapid drop in blood pressure that can even lead to fainting (anaphylactic reactions), inflammation of the face, angina (chest pain or discomfort, known as angina pectoris), unpleasant sensation, skin rash, itching, exanthema (skin rash), skin swelling (hives).
Also, some changes in blood test results have been observed, including:
Reduction in the number of a type of blood cell, called platelets (thrombocytopenia).
Rare side effects (can affect up to 1 in 1,000 people):
Renal function deterioration, lack of energy; intestinal angioedema: swelling in the intestine that occurs with symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Also, some changes in blood test results have been observed, including:
Increased potassium in blood.
Hydrochlorothiazide:
Very frequent side effects (can affect more than 1 in 10 people):
Changes in blood tests, including: increased blood fat and uric acid levels.
Frequent side effects (can affect up to 1 in 10 people):
Confusion, abdominal pain, stomach discomfort, feeling of swelling, diarrhea, nausea, vomiting, constipation, glucose excretion in urine.
Also, some changes in blood test results have been observed, including:
Increased levels of creatinine, urea, calcium, and sugar in blood, decreased levels of chloride, potassium, magnesium, and sodium in blood. Increased serum amylase (hyperamylasemia).
Rare side effects (can affect up to 1 in 100 people):
Loss of appetite, severe difficulty breathing, skin allergic reactions (hypersensitivity reactions), worsening of pre-existing myopia, erythema, light sensitivity skin reactions, itching, purple spots on the skin due to small hemorrhages (purpura), skin swelling (hives).
Rare side effects (can affect up to 1 in 1,000 people):
Salivary gland inflammation and pain, decreased number of white blood cells, decreased number of platelets in blood, anemia, bone marrow depression, restlessness, depression, sleep problems, feeling of loss of interest (apathy), tingling and numbness, seizures, yellowish perception of objects when looking at them, blurred vision, dry eyes, irregular heartbeat, inflammation of blood vessels, blood clots (thrombosis or embolism), lung inflammation, fluid accumulation in lungs, pancreatitis, jaundice, biliary tract infection, symptoms of lupus erythematosus such as skin rash, joint pain, and cold hands and fingers, skin allergic reactions, skin peeling and blistering, non-infectious kidney inflammation (interstitial nephritis), fever, muscle weakness (which sometimes causes movement alteration).
Very rare side effects (can affect up to 1 in 10,000 people):
Electrolyte imbalance that can cause abnormally low levels of chloride in blood (hypochloremic alkalosis),intestinal obstruction (paralytic ileus).
Acute respiratory distress (symptoms include severe difficulty breathing, fever, weakness, and confusion).
Side effects of unknown frequency (cannot be estimated from available data):
Decreased vision or eye pain (possible signs of fluid accumulation in the vascular layer of the eye (choroidal hemorrhage) or acute angle-closure glaucoma).
Skin and lip cancer (non-melanoma skin cancer).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging and in the blister (after “CAD.:”).The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medications at the SIGRE point of the pharmacy.If in doubt, ask your pharmacist how to dispose of unused packaging and medications. This will help protect the environment.
Composition of Ixia Plus
The active ingredients are:
Ixia Plus 20 mg/25 mg: each film-coated tablet contains 20 mg of olmesartan medoxomil and 25 mg of hydrochlorothiazide.
The other components (excipients) are: microcrystalline cellulose, lactose monohydrate*, hypromellose, low-substitution hypromellose, magnesium stearate, titanium dioxide (E 171), talc, hypromellose, and iron(III) oxides (E 172).
*See previous section “Ixia Plus contains lactose”
Appearance of the product and contents of the package
Ixia Plus 20 mg/25 mg is presented in the form of film-coated tablets, pink in color, round, 8.5 mm in diameter, with the inscription “C24” on one side.
Ixia Plus film-coated tablets are presented in packages of 14, 28, 30, 56, 84, 90, 98, and 10 x 28 tablets, and in packages with pre-cut single-dose blisters of 10, 50, and 500 tablets.
Not all packages are marketed.
Holder of the marketing authorization:
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG, S.A.
1 Avenue de la Gare L-1611
Luxembourg
Local representative:
Laboratorios Menarini, S.A.
Alfonso XII, 587 - Badalona (Barcelona) Spain
Responsible for manufacturing:
DAIICHI SANKYO EUROPE GmbH
Luitpoldstrasse 1
85276 Pfaffenhofen
Germany
or
BERLIN-CHEMIE AG
Glienicker Weg 125, D-12489 Berlin
Germany
or
QUALIPHAR N.V.
Rijksweg 9, 2880 Bornem
Belgium
or
Menarini - Von Heyden GmbH
Leipziger Strasse 7-13, 01097 Dresden
Germany
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria: Mencord Plus
Bélgica: Belsar Plus
Chipre: Olartan-plus
República Checa: Sarten Plus H
Estonia: Mesar plus
Alemania: Votum plus
Grecia: Olartan-plus
Francia: CoOlmes, Alteis Duo
Hungría: Laresin Plus
Irlanda: Omesar Plus
Italia: Olprezide
Letonia: Mesar plus
Lituania: Mesar plus
Luxemburgo: Belsar Plus
Malta: Omesar plus
Polonia: Revival Plus
Portugal: Olsar Plus
Eslovaquia: Tenzar Plus
España: Ixia Plus
Last review date of this leaflet:01/2025
Other sources of information
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.